News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
ECOG-ACRIN is now enrolling ComboMATCH-E5 Treatment Trial for patients with advanced Solid Tumors
Apr 1, 2025, 11:50

ECOG-ACRIN is now enrolling ComboMATCH-E5 Treatment Trial for patients with advanced Solid Tumors

ECOG-ACRIN Cancer Research Group shared a post on X:

“ComboMATCH Treatment Trial E5, led by Kristen Spencer of Perlmutter Cancer Center at NYU Langone Health and Dustin Deming of UW Health | Carbone Cancer Center, is a randomized phase 2 study of sotorasib with or without panitumumab in advanced Solid Tumors.

Learn more here.”

cancer Carbone Cancer Center ComboMATCH-E5 Dustin Deming of UW Health ECOG-ACRIN Cancer Research Group fight against cancer Global fight against cancer Kristen Spencer NYU Langone Health OncoDaily Oncology Panitumumab Perlmutter Cancer Center solid tumors Sotorasib
Special Coverage
Blog
Apr 1, 2025, 16:18
The EBMT 2025 Election Results
Career
Apr 1, 2025, 16:02
Jay Bhattacharya begins his tenure as the 18th NIH Director - National Institutes of Health
Positive
Apr 1, 2025, 15:45
Mark Lanasa: Positive CHMP opinion for BeOne Medicines' first-line immunotherapy in ES-SCLC
Blog
Apr 1, 2025, 15:09
Hagop Kantarjian: Success, optimism, and challenges on the therapeutic horizon of acute myeloid leukemia
Blog
Apr 1, 2025, 15:04
Call for Papers: AI in Immune-Related Adverse Events (irAEs) - AI in Precision Oncology
Career
Apr 1, 2025, 14:57
Sharon Burk completes PhD with groundbreaking research - Sbarro Health Research Organization
Blog
Apr 1, 2025, 14:35
Douglas Flora: The messy truth behind healthcare's coming AI adoption
Blog
Apr 1, 2025, 14:31
Zainab Shinkafi-Bagudu: Processed meats and fried snacks may increase the risk of colorectal cancer
Societies
Apr 1, 2025, 14:08
Myeloma Paper of the Day, April 1st, suggested by Robert Orlowski
Blog
Apr 1, 2025, 12:54
CTOS Communications Committee's survey to understand your engagement with social media
Science
Apr 1, 2025, 12:48
Yan Leyfman: Dual-Targeted CAR-T Therapy Shows 100% Response in MCL
Blog
Apr 1, 2025, 12:43
By 2040, the global burden of colorectal cancer is expected to rise by 63% - Digestive Cancers Europe